Niraparib therapy in patients with newly diagnosed advanced ovarian cancer (PRIMA/ENGOT-OV26/GOG-3012 study)

A. Gonzalez Martin; B. Pothuri; I. B. Vergote; R. D. Christensen; W. Graybill; M. R. Mirza; C. McCormick; D. Lorusso; P. Hoskins; G. Freyer; F. Backes; K. Baumann; A. Redondo; R. G. Moore; C. Vulsteke; R. E. O'Cearbhaill; B. Lund; Y. Li; D. Gupta; B. J. Monk

doi:10.1093/annonc/mdz394.052

Niraparib therapy in patients with newly diagnosed advanced ovarian cancer (PRIMA/ENGOT-OV26/GOG-3012 study)

A. Gonzalez Martin, B. Pothuri, I. B. Vergote, R. D. Christensen, W. Graybill, M. R. Mirza, C. McCormick, D. Lorusso, P. Hoskins, G. Freyer, F. Backes, K. Baumann, A. Redondo, R. G. Moore, C. Vulsteke, R. E. O'Cearbhaill, B. Lund, Y. Li, D. Gupta, B. J. Monk

Research output: Contribution to journal › Conference abstract in journal › Research › peer-review

Original language	English
Journal	Annals of Oncology
Volume	30
Issue number	Suppl. 5
Pages (from-to)	893-893
Number of pages	1
ISSN	0923-7534
DOIs	https://doi.org/10.1093/annonc/mdz394.052
Publication status	Published - 1 Oct 2019
Event	44th Congress of the European Society for Medical Oncology (ESMO): Translating science into better cancer patient care - Barcelona, Spain Duration: 27 Sept 2019 → 1 Oct 2019 Conference number: 44 https://www.esmo.org/Conferences/Past-Conferences/ESMO-Congress-2019

Conference

Conference	44th Congress of the European Society for Medical Oncology (ESMO)
Number	44
Country/Territory	Spain
City	Barcelona
Period	27/09/2019 → 01/10/2019
Internet address	https://www.esmo.org/Conferences/Past-Conferences/ESMO-Congress-2019

Access to Document

10.1093/annonc/mdz394.052

AUB Link

Search for the material in Aalborg University Library's search engine

Cite this

Gonzalez Martin, A., Pothuri, B., Vergote, I. B., Christensen, R. D., Graybill, W., Mirza, M. R., McCormick, C., Lorusso, D., Hoskins, P., Freyer, G., Backes, F., Baumann, K., Redondo, A., Moore, R. G., Vulsteke, C., O'Cearbhaill, R. E., Lund, B., Li, Y., Gupta, D., & Monk, B. J. (2019). Niraparib therapy in patients with newly diagnosed advanced ovarian cancer (PRIMA/ENGOT-OV26/GOG-3012 study). Annals of Oncology, 30(Suppl. 5), 893-893. https://doi.org/10.1093/annonc/mdz394.052

@article{1db6052fdf0e42d58811037bbdafcfea,

title = "Niraparib therapy in patients with newly diagnosed advanced ovarian cancer (PRIMA/ENGOT-OV26/GOG-3012 study)",

author = "{Gonzalez Martin}, A. and B. Pothuri and Vergote, {I. B.} and Christensen, {R. D.} and W. Graybill and Mirza, {M. R.} and C. McCormick and D. Lorusso and P. Hoskins and G. Freyer and F. Backes and K. Baumann and A. Redondo and Moore, {R. G.} and C. Vulsteke and O'Cearbhaill, {R. E.} and B. Lund and Y. Li and D. Gupta and Monk, {B. J.}",

year = "2019",

month = oct,

day = "1",

doi = "10.1093/annonc/mdz394.052",

language = "English",

volume = "30",

pages = "893--893",

journal = "Annals of Oncology",

issn = "0923-7534",

publisher = "Oxford University Press",

number = "Suppl. 5",

note = "44th Congress of the European Society for Medical Oncology (ESMO) ; Conference date: 27-09-2019 Through 01-10-2019",

url = "https://www.esmo.org/Conferences/Past-Conferences/ESMO-Congress-2019",

}

Gonzalez Martin, A, Pothuri, B, Vergote, IB, Christensen, RD, Graybill, W, Mirza, MR, McCormick, C, Lorusso, D, Hoskins, P, Freyer, G, Backes, F, Baumann, K, Redondo, A, Moore, RG, Vulsteke, C, O'Cearbhaill, RE, Lund, B, Li, Y, Gupta, D & Monk, BJ 2019, 'Niraparib therapy in patients with newly diagnosed advanced ovarian cancer (PRIMA/ENGOT-OV26/GOG-3012 study)', Annals of Oncology, vol. 30, no. Suppl. 5, pp. 893-893. https://doi.org/10.1093/annonc/mdz394.052

TY - ABST

T1 - Niraparib therapy in patients with newly diagnosed advanced ovarian cancer (PRIMA/ENGOT-OV26/GOG-3012 study)

AU - Gonzalez Martin, A.

AU - Pothuri, B.

AU - Vergote, I. B.

AU - Christensen, R. D.

AU - Graybill, W.

AU - Mirza, M. R.

AU - McCormick, C.

AU - Lorusso, D.

AU - Hoskins, P.

AU - Freyer, G.

AU - Backes, F.

AU - Baumann, K.

AU - Redondo, A.

AU - Moore, R. G.

AU - Vulsteke, C.

AU - O'Cearbhaill, R. E.

AU - Lund, B.

AU - Li, Y.

AU - Gupta, D.

AU - Monk, B. J.

N1 - Conference code: 44

PY - 2019/10/1

Y1 - 2019/10/1

U2 - 10.1093/annonc/mdz394.052

DO - 10.1093/annonc/mdz394.052

M3 - Conference abstract in journal

SN - 0923-7534

VL - 30

SP - 893

EP - 893

JO - Annals of Oncology

JF - Annals of Oncology

IS - Suppl. 5

T2 - 44th Congress of the European Society for Medical Oncology (ESMO)

Y2 - 27 September 2019 through 1 October 2019

ER -